Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons from Previous Epidemics

JAMA - Journal of the American Medical Association

Volumn 323, Issue 12, 2020, Pages 1129-1130

  Swerdlow, David L ^a   Finelli, Lyn ^b  

^a Pfizer Vaccine Research Statistics   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; CASE FATALITY RATE; DISEASE SEVERITY; EMERGENCY; EPIDEMIC; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA A VIRUS (H1N1); MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; NOTE; PRIORITY JOURNAL; SARS CORONAVIRUS; SARS-RELATED CORONAVIRUS; SAUDI ARABIA; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; UNITED STATES; VIRUS TRANSMISSION; BETACORONAVIRUS; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISASTER PLANNING; HISTORY; INFLUENZA; PANDEMIC; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS PNEUMONIA;

BETACORONAVIRUS; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTIONS; DISASTER PLANNING; EPIDEMICS; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA, HUMAN; PANDEMICS; PNEUMONIA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85082007064     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2020.1960     Document Type: Note

References (10)

1. Swerdlow DL, Finelli L, Bridges CB. 2009 H1N1 influenza pandemic: field and epidemiologic investigations in the United States at the start of the first pandemic of the 21st century. Clin Infect Dis. 2011; 52 (suppl 1): S1-S3. doi: 10.1093/cid/ciq005 21342879
2. Balcan D, Hu H, Goncalves B, Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Medicine. 2009;7(45). doi: 10.1186/1741-7015-7-45
3. Dawood FS, Iuliano AD, Reed C, Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012; 12 (9): 687-695. doi: 10.1016/S1473-3099(12)70121-4 22738893
4. Chowell G, Castillo-Chavez C, Fenimore PW, Kribs-Zaleta CM, Arriola L, Hyman JM. Model parameters and outbreak control for SARS. Emerg Infect Dis. 2004; 10 (7): 1258-1263. doi: 10.3201/eid1007.030647 15324546
5. Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East respiratory syndrome coronavirus transmission. Emerg Infect Dis. 2020; 26 (2): 191-198. doi: 10.3201/eid2602.190697 31961300
6. Rasmussen SA, Watson AK, Swerdlow DL. Middle East respiratory syndrome (MERS). Microbiol Spectr. 2016; 4 (3). doi: 10.1128/microbiolspec.EI10-0020-2016 27337460
7. Swerdlow DL, Pillai SK, Meltzer MI, eds. CDC modeling efforts in response to a potential public health emergency: influenza A(H7N9) as an example. Clin Infect Dis. 2015;60(suppl):S1-S63. https://academic.oup.com/cid/issue/60/suppl_1.
8. Wang D, Hu B, Hu C, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. Published online February 7, 2020. doi: 10.1001/jama.2020.1585 32031570
9. Li Q, Guan X, Wu P, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. Published online January 29, 2020. doi: 10.1056/NEJMoa2001316 31995857
10. World Health Organization. Novel coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed February 4, 2020.